News & Updates

Therapeutic hypothermia beneficial for postcardiac arrest care

12 Oct 2020

Therapeutic hypothermia (TH) improves neurological outcomes for patients who had sustained cardiac arrests, reports a recent meta-analysis.

Therapeutic hypothermia beneficial for postcardiac arrest care

12 Oct 2020

Maternal fexofenadine use not tied to increased risk of adverse foetal outcomes

12 Oct 2020 by

The use of fexofenadine during pregnancy was not associated with an increased risk of adverse foetal outcomes compared with cetirizine use, according to a recent study in Denmark.

Maternal fexofenadine use not tied to increased risk of adverse foetal outcomes

12 Oct 2020

Advanced inflammation a red flag for gallstone disease

11 Oct 2020

Elevated high-sensitivity C-reactive protein levels appear to contribute to an increased risk of gallstone disease, as reported in a study.

Advanced inflammation a red flag for gallstone disease

11 Oct 2020

ARIC study: Stay active, save the kidneys

11 Oct 2020

Being physically active boosts health, and a recent study reports that moving more may reduce the risk of developing chronic kidney disease.

ARIC study: Stay active, save the kidneys

11 Oct 2020

Atenolol is worst antihypertensive agent for pregnant women, says study

11 Oct 2020

Use of atenolol in pregnant women with chronic hypertension appears to significantly increase the risk for small-for-gestational-age infants, suggests a study.

Atenolol is worst antihypertensive agent for pregnant women, says study

11 Oct 2020

Brolucizumab IVI tied to occlusion of retinal arteries, perivenular abnormalities

11 Oct 2020

Intravitreal injection (IVI) of brolucizumab for the treatment of neovascular age-related macular degeneration results in variable occlusion of large or small retinal arteries, or both, and perivenular abnormalities, which characterize retinal vasculitis and intraocular inflammation (IOI), a study has found.

Brolucizumab IVI tied to occlusion of retinal arteries, perivenular abnormalities

11 Oct 2020

Recurrent urinary infection linked to vaginal atrophy

11 Oct 2020

Women with recurrent urinary infection, but not lower urinary tract symptoms, are at heightened risk of vaginal atrophy, a study reports.

Recurrent urinary infection linked to vaginal atrophy

11 Oct 2020

Nutritional support still valuable in well-nourished patients

11 Oct 2020

Even among patients who are already well-nourished, nutritional support provides clinical benefit, such as lower morbidity and fewer infectious complications reports a new meta-analysis.

Nutritional support still valuable in well-nourished patients

11 Oct 2020

Add-on elotuzumab improves long-term survival benefits of lenalidomide/dexamethasone

10 Oct 2020

Inclusion of elotuzumab to a lenalidomide/dexamethasone regimen for patients with relapsed or refractory multiple myeloma improves overall survival in the long run, a recent analysis of the ELOQUENT-2 trial has found.

Add-on elotuzumab improves long-term survival benefits of lenalidomide/dexamethasone

10 Oct 2020

Hormone therapy protects the heart by lowering inflammation

10 Oct 2020 by

One way how hormone therapy with oestradiol may slow the progression of atherosclerotic cardiovascular disease (CVD) in postmenopausal women is through the reduction of inflammatory biomarkers, according to the ELITE* study presented at the NAMS 2020 Annual Meeting.

Hormone therapy protects the heart by lowering inflammation

10 Oct 2020

News & Updates

Filter by Specialty:

Specialty:

Therapeutic hypothermia beneficial for postcardiac arrest care

Therapeutic hypothermia beneficial for postcardiac arrest care

Maternal fexofenadine use not tied to increased risk of adverse foetal outcomes

Maternal fexofenadine use not tied to increased risk of adverse foetal outcomes

Advanced inflammation a red flag for gallstone disease

Advanced inflammation a red flag for gallstone disease

ARIC study: Stay active, save the kidneys

ARIC study: Stay active, save the kidneys

Atenolol is worst antihypertensive agent for pregnant women, says study

Atenolol is worst antihypertensive agent for pregnant women, says study

Brolucizumab IVI tied to occlusion of retinal arteries, perivenular abnormalities

Brolucizumab IVI tied to occlusion of retinal arteries, perivenular abnormalities

Recurrent urinary infection linked to vaginal atrophy

Recurrent urinary infection linked to vaginal atrophy

Nutritional support still valuable in well-nourished patients

Nutritional support still valuable in well-nourished patients

Add-on elotuzumab improves long-term survival benefits of lenalidomide/dexamethasone

Add-on elotuzumab improves long-term survival benefits of lenalidomide/dexamethasone

Hormone therapy protects the heart by lowering inflammation

Hormone therapy protects the heart by lowering inflammation